Sendero Wealth Management LLC Acquires 18,808 Shares of Centene Co. (NYSE:CNC)

Sendero Wealth Management LLC lifted its holdings in Centene Co. (NYSE:CNC - Free Report) by 30.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,348 shares of the company's stock after purchasing an additional 18,808 shares during the period. Sendero Wealth Management LLC's holdings in Centene were worth $4,928,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Park Place Capital Corp increased its holdings in shares of Centene by 1,190.0% in the third quarter. Park Place Capital Corp now owns 387 shares of the company's stock valued at $29,000 after buying an additional 357 shares in the last quarter. Private Trust Co. NA raised its position in shares of Centene by 75.3% during the third quarter. Private Trust Co. NA now owns 773 shares of the company's stock worth $58,000 after purchasing an additional 332 shares during the period. True Wealth Design LLC purchased a new stake in shares of Centene during the third quarter valued at $66,000. Venturi Wealth Management LLC boosted its position in shares of Centene by 77.3% in the 3rd quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company's stock valued at $88,000 after purchasing an additional 507 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in Centene by 104.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,231 shares of the company's stock worth $82,000 after buying an additional 630 shares during the period. 93.63% of the stock is owned by institutional investors and hedge funds.

Centene Stock Performance

Shares of NYSE CNC traded down $0.78 during trading hours on Thursday, hitting $62.37. 1,362,608 shares of the stock were exchanged, compared to its average volume of 4,026,106. The firm has a market capitalization of $31.49 billion, a P/E ratio of 10.85, a P/E/G ratio of 0.83 and a beta of 0.45. Centene Co. has a one year low of $55.03 and a one year high of $81.42. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. The company's 50 day moving average is $60.06 and its 200 day moving average is $67.41.

Insider Buying and Selling at Centene

In related news, Director Thomas Greco bought 17,000 shares of the company's stock in a transaction that occurred on Wednesday, December 18th. The shares were acquired at an average price of $59.75 per share, with a total value of $1,015,750.00. Following the completion of the transaction, the director now owns 19,309 shares of the company's stock, valued at $1,153,712.75. The trade was a 736.25 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director H James Dallas purchased 1,693 shares of Centene stock in a transaction on Monday, December 16th. The stock was bought at an average cost of $59.01 per share, with a total value of $99,903.93. Following the completion of the acquisition, the director now owns 1,693 shares in the company, valued at approximately $99,903.93. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 45,010 shares of company stock worth $2,660,276 over the last ninety days. Company insiders own 0.29% of the company's stock.

Wall Street Analysts Forecast Growth

CNC has been the topic of several analyst reports. JPMorgan Chase & Co. reissued an "overweight" rating and issued a $75.00 target price (down from $80.00) on shares of Centene in a research report on Tuesday, December 17th. Truist Financial reduced their target price on Centene from $89.00 to $84.00 and set a "buy" rating for the company in a report on Friday, December 13th. Barclays raised their price target on shares of Centene from $91.00 to $93.00 and gave the stock an "overweight" rating in a report on Friday, December 13th. Wells Fargo & Company decreased their target price on shares of Centene from $91.00 to $90.00 and set an "overweight" rating for the company in a research note on Monday, November 4th. Finally, Jefferies Financial Group lowered Centene from a "hold" rating to an "underperform" rating and cut their price objective for the stock from $68.00 to $52.00 in a report on Tuesday, December 10th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, Centene has a consensus rating of "Moderate Buy" and an average target price of $80.92.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.